AbbVie and Novartis recently became the first drugmakers to file lawsuits challenging Oregon’s new law prohibiting 340B contract pharmacy restrictions. [...] …
Articles by : William Newton, Associate Editor/Senior Writer
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Health Resources and Services Administration (HRSA) today unveiled its highly anticipated 340B rebate guidance, proposing a pilot program that [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Three federal appeals judges—who have all ruled on 340B matters in the past—will hear oral arguments in September in a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Three patient groups are urging a federal appeals court to back drugmaker 340B rebate models they argue would bring transparency [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Nearly 80 advocates marched toward Capitol Hill yesterday in a record turnout for the fourth annual “Defend 340B March” in [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Although President Donald Trump’s nearly 900-page “big beautiful bill” never mentions the 340B program, experts warn that the new law’s [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Washington, D.C. federal appellate court on Friday consolidated multiple drug industry appeals challenging the government’s authority to preapprove 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In a first for the agency, the Centers for Medicare and Medicaid Services (CMS) is proposing to track 340B drugs [...] …